
Mark Sorin
@sorin_mark
@McGill_MDPhD | Vanier Scholar @CIHR_IRSC | Passionate about research in lung cancer & immunotherapy
ID: 1120695205911584768
23-04-2019 14:25:33
300 Tweet
622 Followers
1,1K Following



#McGill research included in Québec Science’s top 10 of the year reporter.mcgill.ca/mcgill-researc… Chaque année, nos équipes de recherche repoussent les frontières du savoir. Nous les félicitons pour leurs réussites et leur nomination aux Découvertes de l'année 2024 de Québec Science.

Our nature paper (Elham Karimi Morteza Rezanejad @DanielaQuail Joubert, Philippe @loganawalsh and many others) was selected as a top 10 science discovery in Quebec! The top discovery is determined based on a vote. Vote for lung cancer and AI! quebecscience.qc.ca/decouverte2023…

Bravo au lauréat de janvier du prix Relève étoile Jacques-Genest du FRQ - secteur Santé, Mark Sorin McGill University McGill MD-PhD Program Rosalind & Morris Goodman Cancer Institute! #communautéFRQ #cancer Morteza Rezanejad Lysanne Desharnais Simon Milette Miranda Yu @SarahMaritan Roni Rayes Jonathan Spicer MD PhD @DanielaQuail t.ly/jM7uh


🚨📣Today our editorial with Alessandro Russo in JAMA Oncology The Chemoimmunotherapy Revolution in Resectable NSCLC—The Times They Are A-Changin’ on the terrific paper of Jonathan Spicer MD PhD and team! The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai jamanetwork.com/journals/jamao…

So very proud of Mark Sorin who I have the pleasure of co-supervising with @loganawalsh Rosalind & Morris Goodman Cancer Institute! He came to me with the idea of this meta-analysis over a year ago and this project is his concept AND execution from start to finish! Congrats Mark! This is important stuff for

These findings highlight the rationale for recent changes in our practices of neoadjuvant therapy for NSCLC. Disseminating this info and educating everyone will be key to minimizing disparities in treatment patterns. Mark Sorin Boris Sepesi MD FACS Patrick Forde Jonathan Spicer MD PhD

Beautiful study! Congratulations Mark Sorin Jonathan Spicer MD PhD and all of the other authors. Incredibly comprehensive compilation of neoadjuvant chemoimmunotherapy data!


Neoadjuvant chemo-immunotherapy is superior to neoadjuvant chemotherapy across surgical, pathological and efficacy outcomes for patients with resectable NSCLC and improves EFS in patients with tumor PD-L1 <1%. ja.ma/4a2G0EH Mark Sorin Jonathan Spicer MD PhD




Check out this awesome new study by the spatial biologists Rosalind & Morris Goodman Cancer Institute led by Lysanne Desharnais Mark Sorin and PI @loganawalsh! Few studies provide such detail contrasting the spatial TME of LUSC and LUAD: the two dominant NSCLC histologies! nature.com/articles/s4146…
